Zhaoke Ophthalmology Limited

6622.HK | Healthcare | HKSE
$3.06
-0.08 (-2.55%)

Key Metrics

Market Cap
$1.67B
P/E Ratio
-5.56
EPS
$-0.55
Beta
N/A
Dividend Yield
N/A
ROE
-15.44%
Current Ratio
4.40

Company Information

Industry
Biotechnology

About Zhaoke Ophthalmology Limited

Zhaoke Ophthalmology Limited an ophthalmic pharmaceutical company engages in the research development and commercialization of therapies that address unmet medical needs in the Peoples Republic of China It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments including dry eye diseases wet agerelated macular degeneration diabetic macular edema myopia and glaucoma The company was formerly known as China Ophthalmology Focus Limited Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou the Peoples Republic of China

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2024-08-29 $-0.15 $-0.37 +-59.2%
2024-03-27 $-0.31 $-0.56 +-45.1%
2023-08-23 $-0.46 $-0.44 4.9%
2023-03-27 $-0.51 $-0.45 12.5%

Financial Ratios (TTM)

Gross Margin
49.28%
Operating Margin
-1,093.26%
Net Margin
-787.13%
ROA
-13.45%
Price to Book
0.90
Price to Sales
43.60